Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Kairos Pharma Presents Phase 2 Trial Of ENV-105 In Advanced Prostate Cancer As ESMO Meeting

Author: Benzinga Newsdesk | October 20, 2025 07:08am

Interim efficacy analysis highlights potential value of combination therapy of ENV-105 and apalutamide following positive safety data

Posted In: KAPA